Invited Speaker Profiles

  • Pia Raanani, Israel, Congress Chair

    Pia Raanani, Israel, Congress Chair

    Dr Pia Raanani MD is Clinical Full Professor in Hematology at the Sackler School of Medicine, Tel-Aviv University. She has been Head of the Division of Hematology and Hemato-oncology at the Rabin Medical Center, Petah-Tikva Israel since 2013. 
  • Jane Apperley, UK

    Jane Apperley, UK

    Prof Jane Apperley qualified in Medicine in Birmingham and trained in internal medicine and haematology in Birmingham, London, Boston and Cambridge. She is currently the Clinical Director of Adult Haematology and Chair of the Academic Centre for Haematology at Imperial College London. 
  • Robin Foà, Italy

    Robin Foà, Italy

    Professor and Head of Hematology, ‘Sapienza’ University of Rome. He earned his medical degree in Turin, Italy, and specialized in pediatrics and in hematology. Worked at the MRC Leukaemia Unit, Hammersmith Hospital, London between 1976 and 1979.
  • Robert Gale, UK

    Robert Gale, UK

    Robert Peter Gale is currently Visiting Professor of Haematology at the Haematology Research Center, Division of Experimental Medicine, Department of Medicine, Imperial College London; Honorary Professor of Hematology at the Institute of Hematology at Peking Union Medical College and on the Clinical Faculty at the University of California Los Angeles.
  • Nicola Gökbuget, Germany

    Nicola Gökbuget, Germany

    Nicola Gökbuget is since 1990 member of the Department for Internal Medicine II, Hematology/Oncology of the University Hospital in Frankfurt. She is head of the Study Center of the department, head of the Study Center of the University Cancer Center (UCT) and one of the Scientific Task Force Directors at the UCT.
  • Elad Jacoby, Israel

    Elad Jacoby, Israel

    Dr. Elad Jacoby has graduated from the Sackler School of Medicine, Tel Aviv University, and was trained in pediatric hematology and oncology at the Johns Hopkins University and the National Cancer Institute, focusing on cellular therapies.
  • Ran Kornowski, Israel

    Ran Kornowski, Israel

    Ran Kornowski, MD, FACC, FESC is the director of the cardiology department and institute of interventional cardiology at Rabin Medical Center in Petach Tikva, Israel. He is a full Professor of cardiovascular medicine and holds a Cathedra focusing upon the research of cardiovascular interventions and cardiac surgery at Tel Aviv University, the “Sackler” School of Medicine in Tel Aviv, Israel. 
  • William Krüger, Germany

    William Krüger, Germany

    Dr. William Krüger is adjunct professor at the University Medical Centre Greifswald. He is working as a senior physician and has leaded the allogeneic stem cell transplantation since 2012.

  • Avi Leader, Israel

    Avi Leader, Israel

    Avi Leader received his MD from the Hebrew University, Jerusalem, Israel in 2007 and subsequently specialized in Internal Medicine & Hematology. From 2016 to 2018 he completed a clinical and research fellowship at Maastricht University, the Netherlands, in the area of cancer and thrombosis. 
  • Frédéric Millot, France

    Frédéric Millot, France

    Frédéric Millot is a Professor of Pediatrics at the University of Poitiers (France) and currently heads the pediatric department of the University Hospital of Poitiers. He is recognized for his clinical research concerning childhood chronic myeloid leukemia (CML) and he has published many peer-reviewed articles in this field.
  • Tadeusz Robak, Poland

    Tadeusz Robak, Poland

    Tadeusz Robak, MD, PhD, is Professor of Hematology at the Medical University of Lodz and since 1997 head of the Department of Hematology at the Medical University and Copernicus Memorial Hospital in Lodz.
  • Uri Rozovski, Israel

    Uri Rozovski, Israel

    Born and raised in Israel, Dr. Rozovski earned his medical degree at Ben-Gurion University of the Negev, Israel in 2001.  After he completed his residency in internal medicine and fellowship in hematology at Tel Aviv Sourasky Medical Center in 2010, he spent 3 years at MD Anderson Cancer Center at the department of leukemia doing mainly translational research with a prime focus on understanding the pathobiology of Chronic Lymphocytic Leukemia.
  • Giuseppe Saglio, Italy

    Giuseppe Saglio, Italy

    Giuseppe Saglio is a Professor of Internal Medicine and Haematology at the University of Turin. He is Director of the Department of Clinical and Biological Sciences o at the San Luigi University Hospital (University of Turin) and Director of the Division of Hematology of the Mauriziano Hospital in Turin.
  • Nicholas Short, USA

    Nicholas Short, USA

    Dr. Nicholas Short is an Assistant Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center. He attended Baylor College of Medicine for medical school, and then completed internal medicine residency at Brigham and Women’s Hospital, followed by hematology/oncology fellowship at The University of Texas MD Anderson Cancer Center. 
  • Radek C. Skoda, Switzerland

    Radek C. Skoda, Switzerland

    Radek Skoda is Professor of Molecular Medicine and head of the Department of Biomedicine at the University of Basel and the University Hospital Basel. His research interests are focused on the molecular pathogenesis of myeloproliferative neoplasms. 
  • Simona Soverini, Italy

    Simona Soverini, Italy

    Dr Simona Soverini is Assistant Professor at the Department of Experimental, Diagnostic and Specialty Medicine of the University of Bologna, in Italy. Dr Soverini graduated with a degree in Biological Sciences in 1999 and subsequently earned a PhD in Clinical and Experimental Haematology from the University of Bologna. 
  • Wendy Stock, USA

    Wendy Stock, USA

    Dr. Stock obtained her BS in biology from the University of Illinois, a MA in zoology from the University of California, Davis and graduated from Rush Medical College in 1985.  From 1985-1988, she was a resident in Internal Medicine at the University of Chicago and completed her hematology-oncology fellowship at the University of Chicago in 1993. 
  • Richard Stone, USA

    Richard Stone, USA

    Richard Stone, MD, is the Chief of Staff and Director of Translational Research for the Adult Leukemia Program at Dana-Farber, and Professor of Medicine at Harvard Medical School. Dr. Stone is nationally recognized for his translational and clinical research concerning blood and bone marrow malignancies including acute leukemia, myeloproliferative disorders and myelodysplastic syndrome [MDS] (a bone marrow failure state that may convert to leukemia).
  • Hugo ten Cate, The Netherlands

    Hugo ten Cate, The Netherlands

    Graduated in medicine at the University of Amsterdam (1987). PhD thesis on “Clinical and experimental studies with a low molecular weight heparinoid”, University of Amsterdam (1987).  Postdoctoral training at the laboratory of Prof. Robert D Rosenberg and Dr. Kenneth A Bauer, Beth Israel Hospital and Harvard Medical School Boston on mechanisms of inflammation associated coagulation activity (1988-1990).
  • Ofir Wolach, Israel

    Ofir Wolach, Israel

    Ofir Wolach earned his MD at Tel-AVIV University. He completed Internal Medicine residency and Hematology fellowship at Rabin Medical Center, Petah-Tikva, Israel.